FR2016468B1 - - Google Patents

Info

Publication number
FR2016468B1
FR2016468B1 FR696929356A FR6929356A FR2016468B1 FR 2016468 B1 FR2016468 B1 FR 2016468B1 FR 696929356 A FR696929356 A FR 696929356A FR 6929356 A FR6929356 A FR 6929356A FR 2016468 B1 FR2016468 B1 FR 2016468B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR696929356A
Other languages
French (fr)
Other versions
FR2016468A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of FR2016468A1 publication Critical patent/FR2016468A1/fr
Application granted granted Critical
Publication of FR2016468B1 publication Critical patent/FR2016468B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • C07C53/136Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems
    • C07C53/138Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems containing an adamantane ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/38Acyl halides
    • C07C53/44Acyl halides containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/36Acyl halides
    • C07C55/38Acyl halides containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes
FR696929356A 1968-08-27 1969-08-27 Expired FR2016468B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40968/68A GB1274652A (en) 1968-08-27 1968-08-27 Adamantanyl-alkylamine derivatives and their preparation

Publications (2)

Publication Number Publication Date
FR2016468A1 FR2016468A1 (en) 1970-05-08
FR2016468B1 true FR2016468B1 (en) 1973-06-08

Family

ID=10417493

Family Applications (1)

Application Number Title Priority Date Filing Date
FR696929356A Expired FR2016468B1 (en) 1968-08-27 1969-08-27

Country Status (12)

Country Link
JP (3) JPS5010856B1 (en)
AT (1) AT307380B (en)
BE (1) BE737975A (en)
CH (3) CH553149A (en)
DE (1) DE1943404A1 (en)
DK (1) DK131721C (en)
FR (1) FR2016468B1 (en)
GB (1) GB1274652A (en)
IE (1) IE33929B1 (en)
IL (1) IL32892A (en)
NL (1) NL6913046A (en)
SE (1) SE364037B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS507356A (en) * 1973-05-22 1975-01-25
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
SE0103836D0 (en) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
SE0300480D0 (en) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
ITTO20030668A1 (en) 2003-09-02 2005-03-03 Rotta Res Lab S P A O Ra Rottapharm DERIVATIVES OF ADAMANTAN EQUIPPED WITH NEUROPROTECTIVE, ANTIDEPRESSIVE AND ANTI-ISCHEMIC ACTIVITY AND PROCEDURE FOR THEIR PREPARATION.
WO2008114002A1 (en) 2007-03-22 2008-09-25 Astrazeneca Ab Quinoline derivatives for the treatment of inflammatory diseases
PE20091036A1 (en) 2007-11-30 2009-08-15 Astrazeneca Ab QUINOLINE DERIVATIVE AS ANTAGONIST OF THE P2X7 RECEPTOR
CN109593042B (en) * 2018-12-24 2021-12-07 陕西莱特迈思光电材料有限公司 Organic electroluminescent material and organic electroluminescent device comprising same
CN114181091A (en) * 2021-12-27 2022-03-15 苏州久显新材料有限公司 Synthesis process of adamantane triphenylamine

Also Published As

Publication number Publication date
IE33929B1 (en) 1974-12-11
GB1274652A (en) 1972-05-17
IE33929L (en) 1970-02-27
DK131721C (en) 1976-01-26
NL6913046A (en) 1970-03-03
JPS4939256B1 (en) 1974-10-24
CH538442A (en) 1973-06-30
BE737975A (en) 1970-02-26
CH553149A (en) 1974-08-30
IL32892A (en) 1975-04-25
FR2016468A1 (en) 1970-05-08
JPS5010856B1 (en) 1975-04-24
DE1943404A1 (en) 1970-12-17
JPS4939257B1 (en) 1974-10-24
SE364037B (en) 1974-02-11
DK131721B (en) 1975-08-25
AT307380B (en) 1973-05-25
CH551365A (en) 1974-07-15
IL32892A0 (en) 1969-11-12

Similar Documents

Publication Publication Date Title
AU1946070A (en)
AU2374870A (en)
JPS4939257B1 (en)
AU6168869A (en)
AU6171569A (en)
AU2580267A (en)
AR203075Q (en)
BE720950A (en)
BE709479A (en)
BE727533A (en)
BE727421A (en)
BE727719A (en)
BE728120A (en)
BE727395A (en)
AU2496167A (en)
BE726921A (en)
BE726859A (en)
BE726347A (en)
BE726332A (en)
BE728618A (en)
BE720001A (en)
BE719099A (en)
BE709496A (en)
BE709484A (en)
BE727591A (en)

Legal Events

Date Code Title Description
ST Notification of lapse